Chapter 9 of 25
- MRI / expert ultrasound: local extent
- CT / PET-CT: selected nodal and distant assessment
- Biopsy uncertain findings when useful
- Combine results with examination and pathology
What you will learn
Compare MRI, CT and PET-CT; understand local and distant spread; prepare for imaging safely.
Looking closely at the pelvis
Pelvic MRI shows soft tissues in detail. It can help assess tumour size, the remaining normal cervix, extension into the vagina or parametrium, and relationships to bladder and rectum. The parametrium is tissue beside the cervix containing vessels and other structures. Expert ultrasound can provide useful local information in selected settings, but a routine abdominal scan is not equivalent to a specialist staging assessment.
Very small cancers diagnosed completely in an excision may not require the same imaging as a large visible tumour. A scan can miss microscopic disease, so pathology and examination remain essential. A report saying “no visible mass” does not overturn a biopsy-confirmed microscopic cancer.
Nodes and distant organs
CT examines areas such as chest, abdomen and pelvis for enlarged nodes, organ lesions and urinary obstruction. PET-CT combines anatomical imaging with a tracer showing metabolic activity and can assist nodal or distant staging in appropriate patients. Infection and inflammation can also take up tracer; a bright spot is not automatically cancer. Small deposits may be below detection limits.
Pelvic lymph nodes are regional drainage stations. Para-aortic nodes lie higher in the abdomen and affect radiation planning and FIGO stage. Depending on the situation, suspicious findings may need biopsy or surgical assessment before committing someone to a major change in treatment intent. The team weighs how much the answer would change care against the risks and delay of another procedure.
Other investigations are selective
Blood counts, kidney function and other laboratory tests help assess treatment fitness. Kidney obstruction, called hydronephrosis, may require drainage with a stent or nephrostomy before therapy. Cystoscopy or proctoscopy examines the bladder or rectum when invasion is suspected; these are not automatically needed for every patient. Mucosal invasion has a particular staging meaning, unlike simple contact or swelling beside an organ.
A chest symptom, bone pain or neurological symptom can justify a targeted investigation. Routine scans of every body part are rarely useful. Tumour markers do not replace examination, biopsy or imaging and are not a universal cervical cancer screening test.
Preparing and interpreting results
Tell the imaging team about pregnancy, kidney disease, contrast reactions, implanted devices and severe claustrophobia. MRI preparation and PET-CT instructions differ; follow the imaging department's advice about food, medicines and blood sugar rather than altering treatment yourself. Ask about travel, positioning and pain control if lying still is difficult.
Reports use words such as “indeterminate,” “suspicious” and “consistent with.” These express different levels of certainty. Ask which findings are established, which remain uncertain and whether a further test would alter the plan. Keep scan images as well as written reports when transferring care.
Misconception and common question
“A negative PET-CT guarantees no cancer cells remain” is false. Can imaging alone assign my treatment? No: stage, pathology, examination, fitness and preferences are considered together, often at a tumour board.
Take-home messages
Know the purpose of each scan. Clarify uncertain findings before assuming the worst. Imaging contributes to staging but does not replace pathology or an individualized clinical assessment.
References and review status
- Cibula et al. ESGO/ESTRO/ESP cervical cancer guidelines, 2023 update
- NCI — Cervical cancer diagnosis
- Bhatla et al. Cancer of the cervix uteri: FIGO Cancer Report 2025
Evidence/editorial check: 28 October 2026. AI-assisted preparation is separate from physician sign-off. Individual physician review is not recorded. Local approvals, resources and clinical guidance must be confirmed by the treating team.
Evidence scope and update policy